Retatrutide 10mg
99.4% HPLC PurityA triple GLP-1, GIP and glucagon receptor agonist, supplied as a 10mg lyophilised vial.
A$129.99AUD
New
Tirzepatide 40mg
SKU: PEP-021-40MG
A dual GIP and GLP-1 receptor agonist, supplied as a 40mg lyophilised vial. Research use only. Preorder — ships with the first batch.
Read the full description ↓A$201.59AUDA$251.99Sale
Price includes GST
Preorder: ships with the next batch
✓Free shipping on orders over $250 AUD
✓Australia Post tracked — Standard $12.99 / Express $18.99
✓Dispatched next business day (orders before 11PM AEST)
Frequently Bought Together
Retatrutide 20mg
99.4% HPLC PurityThe same triple receptor agonist as our 10mg vial, supplied at double the strength.
A$219.99AUD
Retatrutide 30mg
99.4% HPLC PurityThe same triple receptor agonist as our 10mg vial, supplied at triple the strength.
A$299.99AUD
Key Research Features
- Preorder — ships with the first batch
- Batch testing documentation published per batch
- Lyophilised for stability
- For in-vitro laboratory research only
Usage & Storage
- Quantity
- 40mg / vial
- Storage Temp
- −20°C for long-term storage
- Storage Conditions
- Store lyophilised at −20°C, protected from light and moisture.
- Packaging
- Sterile, tamper-evident research vial
Description
A dual GIP and GLP-1 receptor agonist, supplied as a 40mg lyophilised vial.
The literature describes its dual incretin receptor activity and its comparison with single GLP-1 agonists in metabolic research models.
This product is currently available to preorder and ships once the first batch has been produced and tested. Strictly for in-vitro laboratory research only.
Frequently Asked Questions: Tirzepatide
A dual GIP and GLP-1 receptor agonist, supplied as a 40mg lyophilised vial. The literature describes its dual incretin receptor activity and its comparison with single GLP-1 agonists in metabolic research models. All use is strictly for in-vitro laboratory research only.
This product is a preorder. It is not held in stock yet and ships with the first batch; you will be emailed when your order is dispatched.
Batch testing documentation is published for each batch once it has been produced and tested. Contact us before ordering if you need it first.
Store lyophilised product at −20°C, protected from light and moisture, and avoid repeated freeze-thaw cycles.
No. Tirzepatide is supplied for in-vitro laboratory research only and is not approved for human consumption or therapeutic use. Scheduling attaches to the substance and changes over time; verify the current status against the TGA Poisons Standard.
Research Use Only: Important Disclaimer
Tirzepatide 40mg is sold strictly for in-vitro laboratory and research purposes only. This product is not intended for human consumption, therapeutic use, cosmetic use, or veterinary application. It has not been evaluated by the Therapeutic Goods Administration (TGA) or any other regulatory body for human use. You must be 18 years of age or older to purchase. By purchasing, you confirm that you are a qualified researcher and will use this product in compliance with all applicable Australian laws and regulations.
Reviews
Questions & Answers
No questions yet — be the first to ask about this product.